US Patent Issued to Immedica Pharma US on Aug. 19 for "Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders" (Pennsylvania Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,477, issued on Aug. 19, was assigned to Immedica Pharma US Inc. (Radnor, Pa.).

"Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders" was invented by Joseph Hulihan (Radnor, Pa.), Alex Aimetti (Radnor, Pa.) and Scott Braunstein (Radnor, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure to methods for treating tuberous sclerosis complex and epilepsy disorders comprising administering to a subject in need thereof a therapeutically effective amount of ganaxolone or a pharmaceutically acceptable salt thereof."

The patent was filed on Oct. 3, 2024, under Application No. 18/905,520.

*For further information, in...